91 related articles for article (PubMed ID: 10456489)
61. Glutathione S-transferase M1 gene polymorphism and susceptibility to endometriosis in a French population.
Baranova H; Bothorishvilli R; Canis M; Albuisson E; Perriot S; Glowaczower E; Bruhat MA; Baranov V; Malet P
Mol Hum Reprod; 1997 Sep; 3(9):775-80. PubMed ID: 9358003
[TBL] [Abstract][Full Text] [Related]
62. [Correlation of genetic polymorphism of cytochrome P4502D6 with dextromethorphan oxidative metabolism in Chinese].
Cai W; Chen B; Tao X; Ling S; Zhang Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Jun; 17(3):181-4. PubMed ID: 10837520
[TBL] [Abstract][Full Text] [Related]
63. Glutathione S-transferase M1 and T1 null allele frequencies among Indonesian ethnics toward improved disease risk assessment.
Prayuni K; Razari I; Yuliwulandari R
Environ Toxicol Pharmacol; 2019 Jan; 65():14-17. PubMed ID: 30471640
[TBL] [Abstract][Full Text] [Related]
64. Phenotype and genotype analysis of debrisoquine hydroxylase (CYP2D6) in a black Zimbabwean population. Reduced enzyme activity and evaluation of metabolic correlation of CYP2D6 probe drugs.
Masimirembwa C; Hasler J; Bertilssons L; Johansson I; Ekberg O; Ingelman-Sundberg M
Eur J Clin Pharmacol; 1996; 51(2):117-22. PubMed ID: 8911874
[TBL] [Abstract][Full Text] [Related]
65. Genotype and allele frequency of CYP2D6 in Tamilian population.
Adithan C; Gerard N; Naveen AT; Koumaravelou K; Shashindran CH; Krishnamoorthy R
Eur J Clin Pharmacol; 2003 Oct; 59(7):517-20. PubMed ID: 12942225
[TBL] [Abstract][Full Text] [Related]
66. Rapid detection of CYP2D6 null alleles by long distance- and multiplex-polymerase chain reaction.
Stüven T; Griese EU; Kroemer HK; Eichelbaum M; Zanger UM
Pharmacogenetics; 1996 Oct; 6(5):417-21. PubMed ID: 8946473
[TBL] [Abstract][Full Text] [Related]
67. Identification of new alleles and the determination of alleles and genotypes frequencies at the CYP2D6 gene in Emiratis.
Qumsieh RY; Ali BR; Abdulrazzaq YM; Osman O; Akawi NA; Bastaki SM
PLoS One; 2011; 6(12):e28943. PubMed ID: 22216145
[TBL] [Abstract][Full Text] [Related]
68. Heterogeneity of the CYP2D6 gene among Malays in Malaysia.
Teh LK; Ismail R; Yusoff R; Hussein A; Isa MN; Rahman AR
J Clin Pharm Ther; 2001 Jun; 26(3):205-11. PubMed ID: 11422605
[TBL] [Abstract][Full Text] [Related]
69. Frequency of certain single-nucleotide polymorphisms and duplication of CYP2D6 in the Jordanian population.
Zihlif M; Imraish A; Irshaid YM
Genet Test Mol Biomarkers; 2012 Oct; 16(10):1201-5. PubMed ID: 22905959
[TBL] [Abstract][Full Text] [Related]
70. The Genetic Variation of CYP2D6 Gene in the Bosnian Population.
Nefic H
Med Arch; 2018 Dec; 72(6):396-400. PubMed ID: 30814768
[TBL] [Abstract][Full Text] [Related]
71. Role of CYP2D6 polymorphism in predicting liver fibrosis progression rate in Caucasian patients with chronic hepatitis C.
Fishman S; Lurie Y; Peretz H; Morad T; Grynberg E; Blendis LM; Leshno M; Brazowski E; Rosner G; Halpern Z; Oren R
Liver Int; 2006 Apr; 26(3):279-84. PubMed ID: 16584388
[TBL] [Abstract][Full Text] [Related]
72. CYP2D6 genotype analysis of a Thai population: platform comparison.
Chamnanphon M; Gaedigk A; Vanwong N; Nuntamool N; Hongkaew Y; Puangpetch A; Sukasem C
Pharmacogenomics; 2018 Aug; 19(12):947-960. PubMed ID: 29992861
[TBL] [Abstract][Full Text] [Related]
73. CYP2D6 genotypes in cigarette smokers and non-tobacco users.
Cholerton S; Boustead C; Taber H; Arpanahi A; Idle JR
Pharmacogenetics; 1996 Jun; 6(3):261-3. PubMed ID: 8807667
[No Abstract] [Full Text] [Related]
74. Genotype and allele frequencies of polymorphic UGT1A9 in the Polish population.
Zakerska O; Skrzypczak-Zielinska M; Mikstacki A; Tamowicz B; Malengowska B; Szalata M; Slomski R
Eur J Drug Metab Pharmacokinet; 2013 Sep; 38(3):217-21. PubMed ID: 23184343
[TBL] [Abstract][Full Text] [Related]
75. Duplication, multiduplication, and amplification of genes encoding drug-metabolizing enzymes: evolutionary, toxicological, and clinical pharmacological aspects.
Ingelman-Sundberg M
Drug Metab Rev; 1999 May; 31(2):449-59. PubMed ID: 10335447
[No Abstract] [Full Text] [Related]
76. Correction to: Relationship between plasma exposure of zolpidem and CYP2D6 genotype in healthy Korean subjects.
Jung EH; Lee CM; Byeon JY; Shin HB; Oh KY; Cho CK; Lim CW; Jang CG; Lee SY; Lee YJ
Arch Pharm Res; 2021 Mar; 44(3):323. PubMed ID: 33515157
[No Abstract] [Full Text] [Related]
77. CYP2D6 and GSTM1 genotypes in a Polish population.
Gawronska-Szklarz B; Wójcicki M; Kuprianowicz A; Kedzierska K; Kedzierski M; Górnik W; Pawlik A
Eur J Clin Pharmacol; 1999 Jul; 55(5):389-92. PubMed ID: 10456489
[TBL] [Abstract][Full Text] [Related]
78. Genetic polymorphisms of CYP2D6, CYP1A1, GSTM1 and p53 genes in a unique Siberian population of Tundra Nentsi.
Duzhak T; Mitrofanov D; Ostashevskii V; Gutkina N; Chasovnikova O; Posukh O; Osipova L; Lyakhovich VV
Pharmacogenetics; 2000 Aug; 10(6):531-7. PubMed ID: 10975607
[TBL] [Abstract][Full Text] [Related]
79. CYP2D6 extensive, intermediate, and poor phenotypes and genotypes in a Polish population.
Niewinski P; Orzechowska-Juzwenko K; Hurkacz M; Rzemislawska Z; Jaźwinska-Tarnawska E; Milejski P; Forkasiewicz Z
Eur J Clin Pharmacol; 2002 Nov; 58(8):533-5. PubMed ID: 12536989
[TBL] [Abstract][Full Text] [Related]
80. Cytochrome P450 2D6 and glutathione S-transferase M1 genotypes and migraine.
Mattsson P; Bjelfman C; Lundberg PO; Rane A
Eur J Clin Invest; 2000 Apr; 30(4):367-71. PubMed ID: 10759887
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
